Skip to content

LABORATOIRES COLIN

Active
Public limited companyfounded 1946active for 79 yearsRue de Fléron 111, 4020 Liège, BelgiumKBO/BCE: BE 0402.455.968

From the official registers: KBO 47 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

LABORATOIRES COLIN has been active since 1946 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €308,352 and a net result of €14,044. Equity is growing by about 9% per year across the filed financial years. Its solvency ranks better than 91% of 15,442 sector peers (NACE 46, financial year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
LABORATOIRES COLINActiveChecked score 57/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 20-12-1946 Normal situation
Legal form
Public limited company
Registered office
Rue de Fléron 111, 4020 Liège
Activity
Wholesale of pharmaceutical and medical goods NACE 46460
Establishment unit
2.003.668.424 4020 Liège, since 01-12-1946
Financial year end
31 December
Peppol
Reachable since 27-04-2026
Company details

Who decides

Board
Board & ownership

How it is doing

57 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2024
Gross margin
€36,128
▼ 56.7%
Turnover
≈ €190,000
estimated
Profit
€14,044
▼ 50.3%
Equity
€308,352
▲ 4.8%
Total assets
€343,593
▼ 11.6%
2025 accounts not filed, 93 days past the deadline
Filed on 15-08-2025PDF
Financials
Why 57raises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed 15-08-2025)lowers riskFounded in 1946Liquidity: current ratio 9.57, cash €111,039, halvedEquity €308,352 (89.7% of total assets)Show the evidence

Checked score

Score 2024
57 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 74% of its sector peers (NACE 46, micro)
A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick = 2023
Strong
Solvency 100=
equity 89.7% of total assets
Liquidity 90-1
short-term debt 10.3% · cash 32.3%
Profitability 74-4
return on assets 4.1%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (26,900 companies, NACE 46, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026lowest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.2%▲ +0.1 percentage points vs 09-2026highest value
Credit of up to €17,000 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance
Liquidity ample (current ratio 9.57, compared with 3.9 in 2023, above the usual 1.5; short-term debt: 10.3% and cash: 32.3% of total assets), and 10.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro): better than 90% on solvency, 89% on liquidity, 61% on profitability and 55% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises risk
raises risk · Figures for financial year 2024 (filed 15-08-2025)
NBB · annual accounts
lowers risk · Founded in 1946
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Liquidity: current ratio 9.57, cash €111,039, halved
NBB · annual accounts
lowers risk · Equity €308,352 (89.7% of total assets)
NBB · annual accounts
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 93 days later.
NBB · 10 filings
Position against the passed deadline
31-12-2025 year end31-07-2026 deadline01-11-2026 today
raises risk · 2024 accounts filed 15 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 15-08-2025, 15 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
not filed
2024
15 days late
2023
23 days late
2022
22 days late
2021
65 days late
2020
6 days late
2019
28 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 17 days after the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage

Key points

  • Positive: Among the best 10% on solvencysector median 39.3% · 15,442 companies 89.7% View
  • Positive: 7 profitable years in a rowprofit 2024: €14,044 7 years View

Documents

Annual accounts at the NBB

All 47 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about LABORATOIRES COLIN

What is the company number of LABORATOIRES COLIN?
0402.455.968. In Belgium the VAT number is the company number with BE in front: BE 0402.455.968.
Where is LABORATOIRES COLIN based?
The registered office is at Rue de Fléron 111, 4020 Liège.Company details
What does LABORATOIRES COLIN do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of LABORATOIRES COLIN?
Public limited company (NV).
When was LABORATOIRES COLIN founded?
On 20-12-1946.
Is LABORATOIRES COLIN still active?
Yes, LABORATOIRES COLIN is an active enterprise in the KBO register.
How many employees does LABORATOIRES COLIN have?
On average 1 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of LABORATOIRES COLIN?
≈ €190,000 in financial year 2024. Estimated from the gross margin of €36,128: probably between €110,000 and €380,000, based on 33 comparable companies, NACE 464.
Is LABORATOIRES COLIN profitable?
In financial year 2024, LABORATOIRES COLIN made a profit of €14,044.
Where can I find the annual accounts of LABORATOIRES COLIN?
LABORATOIRES COLIN filed 47 annual accounts with the National Bank of Belgium, the latest for financial year 2024.Annual accounts 2024 (PDF)

Companies related to LABORATOIRES COLIN

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure